EMA Authorised: Constella (linaclotide) — AbbVie Deutschland GmbH & Co. KG

View source ↗

Summary

The European Medicines Agency authorised Constella (linaclotide) for irritable bowel syndrome, with AbbVie Deutschland GmbH & Co. KG as the marketing authorizat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Constella (linaclotide)

Snippet

Status: Authorised. Therapeutic area: Irritable Bowel Syndrome. MAH: AbbVie Deutschland GmbH & Co. KG. Decision date: 27/01/2026